Cynthia Wei, M.D.

Internal Medicine - Hematology/Oncology
Thoracic Oncology
General Hematology/Oncology

New Patient Appointment Accepting Virtual Visits or 214-645-4673

Biography

Cynthia Wei, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in thoracic oncology and general hematology-oncology.

Dr. Wei earned her medical degree at UT Southwestern. She completed a residency in internal medicine at Indiana University School of Medicine, where she served as Chief Resident. She then gained advanced training in hematology and oncology through a fellowship at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, where she served as Chief Fellow. She also holds a Bachelor of Science from Cornell University.

Certified by the American Board of Internal Medicine, Dr. Wei joined the UT Southwestern faculty in 2023.

Dr. Wei sees patients at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center’s main campus and RedBird locations. Her clinical and research interests include providing patient-centered care to underserved populations and bringing clinical trial options to her patients.

Personal Note

When she’s not at work, Dr. Wei enjoys hiking, traveling, and spending time with her family and dog.

Education & Training

Medical School - UT Southwestern Medical School (2012-2016)
Residency - Indiana University School of Medicine (2016-2019), Internal Medicine
Fellowship - Indiana University School of Medicine (2020-2023), Hematology Oncology

Honors & Awards

Fellow Travel Grant 2023, National Comprehensive Cancer Network
Chief Fellow 2022, Indiana University Hematology Oncology Fellowship
Chief Resident 2019, Indiana University School of Medicine Internal Medicine Residency
Finalist and Oral Speaker 2014, 52nd Annual Medical Student Research Forum of UTSWMC at Dallas

Books & Publications

Publications
- A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer.
  Wei CX, Mamdani H, Gentzler R, Kalra M, Perkins S, Althouse S, Jalal SI, Clinical lung cancer 2023 Jun 24 4 347-352
- Association of immune-related adverse events and efficacy outcomes in phase II trial of consolidation nivolumab plus ipilimumab or nivolumab alone after chemoradiation in patients with unresectable stage III non–small-cell lung cancer (NSCLC).
  Cynthia Wei, Sandra K. Althouse, Hirva Mamdani, Nasser H. Hanna, Greg Andrew Durm Journal of Clinical Oncology 2023 41 16
- Innovation in Resident Core Oncology Education: Switching from an Inpatient Ward Rotation to a Hybrid Model of Inpatient Consultations and Outpatient Clinics.
  King JM, Akel R, Saliba AN, Wei C, Anouti B, Manchanda N, Sinex NC, Grethlein SJ, Goldman M, Journal of cancer education : the official journal of the American Association for Cancer Education 2022 Dec 37 6 1768-1772
- Pearls and perils in the management of germ cell tumors.
  Wei CX, Einhorn LH, Adra N, Current opinion in oncology 2021 May 33 3 206-211
- Adjuvant chemotherapy with CAV/IE for malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): An institutional analysis from Indiana University.
  Cynthia Wei, Clint Cary, Timothy A. Masterson, Richard Foster, Ryan Ashkar, Nabil Adra, Nasser H. Hanna, Lawrence H. Einhorn Journal of Clinical Oncology 2021 39 15
- Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model.
  Wei CX, Zhu M, Petroll M, Robertson DM Investigative ophthalmology & visual science 2014 Aug

Clinical Focus

Thoracic Oncology
General Hematology/Oncology